Brii Biosciences (STU:7SS) ROCE % : 0.82% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Brii Biosciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Brii Biosciences's annualized ROCE % for the quarter that ended in Dec. 2023 was 0.82%.

Brii Biosciences ROCE % Historical Data

The historical data trend for Brii Biosciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brii Biosciences ROCE % Chart

Brii Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-53.19

-151.64

-211.74

-14.86

-5.74

Brii Biosciences Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial				-104.39	-22.68	-7.66	-12.27	0.82

Brii Biosciences ROCE % Calculation

Brii Biosciences's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-23.615	/	( ( (459.272 - 31.023)	+	(410.744 - 16.165) )	/ 2 )
	=	-23.615	/	( (428.249	+	394.579)	/ 2 )
	=	-23.615	/	411.414
	=	-5.74 %

Brii Biosciences's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	3.262	/	( ( (412.22 - 14.381)	+	(410.744 - 16.165) )	/ 2 )
	=	3.262	/	( ( 397.839	+	394.579 )	/ 2 )
	=	3.262	/	396.209
	=	0.82 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Brii Biosciences (STU:7SS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Brii Biosciences ROCE % Related Terms

Thank you for viewing the detailed overview of Brii Biosciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Brii Biosciences (STU:7SS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Brii Biosciences Ltd (STU:7SS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

BRIBF:USA 02137:Hong Kong 7SS:Germany

Address

No. 1 North Yongtaizhuang Road, 3rd Floor, Building 7, Zhongguancun Dongsheng, International Science Park, Haidian District, Beijing, CHN, 100192

Website

https://www.briibio.com

Brii Biosciences Ltd is a biotechnology company based in China and the United States. It is committed towards developing advancing therapies for infectious diseases, such as HBV, HIV, MDR/XDR gram-negative infections, and other illnesses, such as the CNS diseases, which have public health burdens in China and worldwide. The company's pipeline of products includes more than 10 product candidates that focus on infectious diseases and mental illnesses.

Brii Biosciences (STU:7SS) Headlines

No Headlines